Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) Equity Average (2018 - 2025)

Exagen's Equity Average history spans 8 years, with the latest figure at $17.8 million for Q4 2025.

  • For Q4 2025, Equity Average rose 58.81% year-over-year to $17.8 million; the TTM value through Dec 2025 reached $17.8 million, up 58.81%, while the annual FY2025 figure was $13.5 million, 16.27% down from the prior year.
  • Equity Average reached $17.8 million in Q4 2025 per XGN's latest filing, down from $19.6 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $98.9 million in Q2 2021 to a low of $8.0 million in Q1 2025.
  • Average Equity Average over 5 years is $43.2 million, with a median of $31.8 million recorded in 2023.
  • Peak YoY movement for Equity Average: soared 103.61% in 2021, then crashed 62.65% in 2025.
  • A 5-year view of Equity Average shows it stood at $87.9 million in 2021, then plummeted by 43.87% to $49.3 million in 2022, then plummeted by 49.11% to $25.1 million in 2023, then tumbled by 55.36% to $11.2 million in 2024, then surged by 58.81% to $17.8 million in 2025.
  • Per Business Quant, the three most recent readings for XGN's Equity Average are $17.8 million (Q4 2025), $19.6 million (Q3 2025), and $13.7 million (Q2 2025).